88.66
price up icon1.72%   1.50
pre-market  Vorhandelsmarkt:  89.87   1.21   +1.36%
loading
Schlusskurs vom Vortag:
$87.16
Offen:
$87.17
24-Stunden-Volumen:
1.65M
Relative Volume:
1.04
Marktkapitalisierung:
$42.51B
Einnahmen:
$9.93B
Nettoeinkommen (Verlust:
$1.12B
KGV:
39.40
EPS:
2.25
Netto-Cashflow:
$1.58B
1W Leistung:
+3.15%
1M Leistung:
+3.82%
6M Leistung:
-0.14%
1J Leistung:
-2.36%
1-Tages-Spanne:
Value
$87.06
$88.71
1-Wochen-Bereich:
Value
$85.52
$88.71
52-Wochen-Spanne:
Value
$80.48
$101.10

Alcon Inc Stock (ALC) Company Profile

Name
Firmenname
Alcon Inc
Name
Telefon
-
Name
Adresse
-
Name
Mitarbeiter
25,599
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-12
Name
Neueste SEC-Einreichungen
Name
ALC's Discussions on Twitter

Vergleichen Sie ALC mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Medical Instruments & Supplies icon
ALC
Alcon Inc
88.66 42.51B 9.93B 1.12B 1.58B 2.25
Medical Instruments & Supplies icon
ISRG
Intuitive Surgical Inc
511.00 183.59B 8.71B 2.48B 1.75B 6.82
Medical Instruments & Supplies icon
BDX
Becton Dickinson Co
181.28 51.10B 20.87B 1.50B 2.59B 5.24
Medical Instruments & Supplies icon
RMD
Resmed Inc
267.40 36.95B 5.02B 1.31B 1.56B 8.91
Medical Instruments & Supplies icon
WST
West Pharmaceutical Services Inc
218.90 15.88B 2.90B 467.20M 306.90M 6.37

Alcon Inc Stock (ALC) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-05-20 Herabstufung Deutsche Bank Buy → Hold
2025-05-14 Bestätigt BTIG Research Buy
2025-03-28 Bestätigt Needham Buy
2025-03-25 Hochstufung BofA Securities Neutral → Buy
2025-01-24 Bestätigt Needham Buy
2025-01-10 Hochstufung Redburn Atlantic Neutral → Buy
2024-12-17 Bestätigt Needham Buy
2024-11-12 Bestätigt Needham Buy
2024-10-10 Hochstufung Redburn Atlantic Sell → Neutral
2024-09-10 Hochstufung RBC Capital Mkts Sector Perform → Outperform
2024-07-15 Hochstufung Morgan Stanley Underweight → Equal-Weight
2024-05-15 Hochstufung Oppenheimer Perform → Outperform
2024-04-10 Eingeleitet Goldman Buy
2024-03-14 Eingeleitet RBC Capital Mkts Sector Perform
2024-02-06 Fortgesetzt KeyBanc Capital Markets Overweight
2024-01-23 Eingeleitet Bernstein Outperform
2023-12-18 Herabstufung Redburn Atlantic Neutral → Sell
2023-12-12 Eingeleitet Stifel Buy
2023-12-04 Herabstufung Morgan Stanley Equal-Weight → Underweight
2023-08-17 Hochstufung JP Morgan Neutral → Overweight
2023-05-30 Fortgesetzt Morgan Stanley Equal-Weight
2023-05-10 Hochstufung Robert W. Baird Neutral → Outperform
2023-03-01 Hochstufung Societe Generale Sell → Hold
2022-12-22 Eingeleitet Mizuho Buy
2022-11-17 Herabstufung Societe Generale Hold → Sell
2022-08-11 Herabstufung Societe Generale Buy → Hold
2022-05-13 Fortgesetzt Credit Suisse Outperform
2022-05-12 Hochstufung Stephens Equal-Weight → Overweight
2022-04-08 Eingeleitet Needham Buy
2022-03-11 Eingeleitet BofA Securities Buy
2022-01-18 Herabstufung Stephens Overweight → Equal-Weight
2022-01-07 Herabstufung Morgan Stanley Overweight → Equal-Weight
2021-10-01 Eingeleitet Oppenheimer Perform
2021-07-14 Eingeleitet Deutsche Bank Buy
2021-05-06 Hochstufung Citigroup Sell → Neutral
2021-03-22 Hochstufung BTIG Research Neutral → Buy
2020-11-12 Herabstufung Guggenheim Buy → Neutral
2020-07-06 Herabstufung Citigroup Neutral → Sell
2020-07-06 Eingeleitet KeyBanc Capital Markets Sector Weight
2020-06-16 Hochstufung Guggenheim Neutral → Buy
2020-04-08 Herabstufung Robert W. Baird Outperform → Neutral
2020-03-26 Hochstufung Argus Hold → Buy
2020-03-24 Hochstufung Societe Generale Sell → Hold
2020-03-13 Hochstufung UBS Neutral → Buy
2020-03-05 Eingeleitet Citigroup Neutral
2020-02-26 Hochstufung Berenberg Hold → Buy
2020-01-08 Eingeleitet Argus Hold
2019-10-29 Eingeleitet Stephens Equal-Weight
2019-08-21 Bestätigt BofA/Merrill Neutral
2019-06-24 Eingeleitet SVB Leerink Mkt Perform
2019-06-14 Eingeleitet BTIG Research Neutral
2019-05-10 Eingeleitet Robert W. Baird Outperform
2019-05-02 Eingeleitet Credit Suisse Outperform
Alle ansehen

Alcon Inc Aktie (ALC) Neueste Nachrichten

pulisher
Jul 22, 2025

What analysts say about Alcon Inc. stockDynamic profit opportunities - Autocar Professional

Jul 22, 2025
pulisher
Jul 22, 2025

What drives Alcon Inc. stock priceFree Trading Strategy Suggestions - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Is Alcon Inc. a good long term investmentFree Consultation - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 21, 2025

Alcon Helps with Back-to-School Prep - MyStateline

Jul 21, 2025
pulisher
Jul 21, 2025

RBC Sticks With Alcon As Equipment Sales Lead Growth - Finimize

Jul 21, 2025
pulisher
Jul 21, 2025

Swiss Stocks Slip As Roche And Alcon Weigh On The Index - Finimize

Jul 21, 2025
pulisher
Jul 21, 2025

Ophthalmic Implants Market: Focused Insights (2025-2030) Featuring Alcon, Carl Zeiss, Bausch + Lomb, Johnson & Johnson and 20 Other Industry Leaders - Yahoo Finance

Jul 21, 2025
pulisher
Jul 20, 2025

Alcon Inc. Stock Analysis and ForecastRapid profit acceleration - Autocar Professional

Jul 20, 2025
pulisher
Jul 17, 2025

September 19th Options Now Available For Alcon (ALC) - Nasdaq

Jul 17, 2025
pulisher
Jul 14, 2025

Alcon Stock Gains Following UNITY VCS' Approval in Canada - MSN

Jul 14, 2025
pulisher
Jul 12, 2025

Alcon’s Clareon PanOptix Pro IOL approved in Canada for cataract patients - Ophthalmology Times Europe

Jul 12, 2025
pulisher
Jul 12, 2025

Stifel Nicolaus Sticks to Their Buy Rating for Alcon (ALC) - The Globe and Mail

Jul 12, 2025
pulisher
Jul 12, 2025

Stifel reiterates Buy rating on Alcon stock, maintains $100 price target - Investing.com Nigeria

Jul 12, 2025
pulisher
Jul 11, 2025

Leadership watch: ViaLase, J&J, Alcon, and myze make executive additions - Eyes On Eyecare

Jul 11, 2025
pulisher
Jul 10, 2025

Stifel reiterates Buy rating on Alcon stock, maintains $100 price target By Investing.com - Investing.com South Africa

Jul 10, 2025
pulisher
Jul 10, 2025

Alcon Adds Noninvasive Treatment Solution, Acquires LumiThera | Business | Jul 2025 - Photonics Spectra

Jul 10, 2025
pulisher
Jul 10, 2025

Alcon Names Julie M. Brewer to its Executive Leadership Team as SVP, President, Global Franchises - VisionMonday.com

Jul 10, 2025
pulisher
Jul 09, 2025

Alcon sees the light with Lumithera buy for dry AMD - BioWorld MedTech

Jul 09, 2025
pulisher
Jul 09, 2025

Alcon’s vitreoretinal-cataract system receives Health Canada approval By Investing.com - Investing.com South Africa

Jul 09, 2025
pulisher
Jul 08, 2025

Alcon to acquire LumiThera for dry AMD treatment device - MSN

Jul 08, 2025
pulisher
Jul 08, 2025

Alcon to purchase LumiThera - Eyes On Eyecare

Jul 08, 2025
pulisher
Jul 08, 2025

Alcon's Unity VCS Gets Health Canada Approval - Nasdaq

Jul 08, 2025
pulisher
Jul 08, 2025

Alcon snaps up LumiThera for light-based AMD treatment - Optics.org

Jul 08, 2025
pulisher
Jul 08, 2025

Alcon Gets Health Canada Approval on Unity Vitreoretinal Cataract System - MarketScreener

Jul 08, 2025
pulisher
Jul 08, 2025

Alcon’s vitreoretinal-cataract system receives Health Canada approval - Investing.com

Jul 08, 2025
pulisher
Jul 08, 2025

Alcon : Names Julie M. Brewer to its Executive Leadership Team as SVP, President, Global Franchises - MarketScreener

Jul 08, 2025
pulisher
Jul 08, 2025

Alcon’s Latest Breakthrough Surgical Technology, Unity VCS, receives Health Canada approval - Nasdaq

Jul 08, 2025
pulisher
Jul 08, 2025

La dernière technologie chirurgicale révolutionnaire d’Alcon, Unity VCS, reçoit l’approbation de Santé Canada - New Castle News

Jul 08, 2025
pulisher
Jul 08, 2025

Alcon Eyes Vitreoretinal Surgery Market Expansion in LumiThera Deal - MarketScreener

Jul 08, 2025
pulisher
Jul 08, 2025

Alcon to acquire LumiThera and its dry AMD light therapy device - Investing.com Australia

Jul 08, 2025
pulisher
Jul 07, 2025

Alcon Inc (ALC) Announces Approval of Clareon PanOptix Pro Intraocular Lens - MSN

Jul 07, 2025
pulisher
Jul 07, 2025

Alcon's Bold Bet on Light Therapy: A New Dawn for Dry AMD and Retinal Dominance - AInvest

Jul 07, 2025
pulisher
Jul 07, 2025

Alcon To Acquire LumiThera - citybiz

Jul 07, 2025
pulisher
Jul 07, 2025

Alcon to acquire LumiThera and its photobiomodulation device for the treatment of dry AMD - Ophthalmology Times

Jul 07, 2025
pulisher
Jul 07, 2025

Alcon To Acquire LumiThera And Its Photobiomodulation Device - Nasdaq

Jul 07, 2025
pulisher
Jul 07, 2025

Alcon to acquire LumiThera and its dry AMD light therapy device By Investing.com - Investing.com South Africa

Jul 07, 2025
pulisher
Jul 07, 2025

Alcon to Acquire LumiThera and Its Photobiomodulation Device for the Treatment of Early and Intermediate Dry Age-Related Macular Degeneration (AMD) - Business Wire

Jul 07, 2025

Finanzdaten der Alcon Inc-Aktie (ALC)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
medical_instruments_supplies RMD
$267.40
price up icon 2.42%
medical_instruments_supplies BDX
$181.28
price up icon 3.39%
medical_instruments_supplies WST
$218.90
price up icon 4.20%
medical_instruments_supplies COO
$73.03
price up icon 2.40%
$65.37
price up icon 2.64%
Kapitalisierung:     |  Volumen (24h):